Carmustine and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Carmustine (carmustine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Methotrexate, and have Burkitt lymphoma.

The phase IV clinical study analyzes which people have Stroke when taking Carmustine. It is created by eHealthMe based on reports of 4,562 people who have side effects when taking Carmustine from the FDA, and is updated regularly.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,328 drugs and 3,028 conditions by eHealthMe. Check the latest studies of Stroke.

On Jun, 24, 2026

4,562 people reported to have side effects when taking Carmustine.
Among them, 17 people (0.37%) have Stroke.

Among these 17 people:

How long have people been on Carmustine when they have Stroke? *

What is the gender of people who have Stroke when taking Carmustine? *

female: 50 %
male: 50 %

What is the age of people who have Stroke when taking Carmustine? *

What are other drugs people take besides Carmustine? *

What are other side effects people have besides Stroke? *

Thrombocytopenia (decrease of platelets in blood): 11 people, 64.71%
Febrile Neutropenia (fever with reduced white blood cells): 9 people, 52.94%
Cytomegalovirus Infection: 8 people, 47.06%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 8 people, 47.06%
Anaemia (lack of blood): 8 people, 47.06%
Hepatotoxicity (chemical-driven liver damage): 8 people, 47.06%
Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 41.18%
Mucosal Inflammation (infection of mucous membrane): 6 people, 35.29%
Lymphoma (cancer that begins in immune system cells): 5 people, 29.41%
Headache (pain in head): 5 people, 29.41%

What are the existing conditions these people have? *

Burkitt Lymphoma (cancer of the lymphatic system): 8 people, 47.06%
Disease Progression: 5 people, 29.41%
Burkitt's Lymphoma (cancer of the lymphatic system): 5 people, 29.41%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 4 people, 23.53%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 2 people, 11.76%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 5.88%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 5.88%
Lymphoma (cancer that begins in immune system cells): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Carmustine and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carmustine:

Carmustine (4,562 reports)

Stroke treatments and more:

Stroke (334,635 reports)

Browse all side effects of Carmustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,328 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,028 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carmustine (the active ingredients of Carmustine) and Carmustine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.